These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37821953)

  • 1. Barriers to penicillin allergy de-labeling in the inpatient and outpatient settings: a qualitative study.
    Alagoz E; Saucke M; Balasubramanian P; Lata P; Liebenstein T; Kakumanu S
    Allergy Asthma Clin Immunol; 2023 Oct; 19(1):88. PubMed ID: 37821953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De-escalation of conflict in forensic mental health inpatient settings: a Theoretical Domains Framework-informed qualitative investigation of staff and patient perspectives.
    Johnston I; Price O; McPherson P; Armitage CJ; Brooks H; Bee P; Lovell K; Brooks CP
    BMC Psychol; 2022 Feb; 10(1):30. PubMed ID: 35168682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognizing the opportunity to directly de-label no-risk penicillin allergies in community pharmacy: a mystery shopper experience.
    Lim A; Khumra S; Dalley A; Bubb G; Chien J; Kong DCM
    Int J Pharm Pract; 2024 Jul; 32(4):267-273. PubMed ID: 38676911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focus group study exploring the issues and the solutions to incorrect penicillin allergy-labelled patients: an antibiotic stewardship patient safety initiative.
    Powell N; Wilcock M; Roberts N; Sandoe J; Tonkin-Crine S
    Eur J Hosp Pharm; 2021 Mar; 28(2):71-75. PubMed ID: 33608433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenge of de-labeling penicillin allergy.
    Stone CA; Trubiano J; Coleman DT; Rukasin CRF; Phillips EJ
    Allergy; 2020 Feb; 75(2):273-288. PubMed ID: 31049971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Penicillin Allergy in the Hospitalized Patient: Opportunities for Antimicrobial Stewardship.
    Chen JR; Khan DA
    Curr Allergy Asthma Rep; 2017 Jun; 17(6):40. PubMed ID: 28540641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a pharmacist-led penicillin allergy de-labelling service in a public hospital.
    du Plessis T; Walls G; Jordan A; Holland DJ
    J Antimicrob Chemother; 2019 May; 74(5):1438-1446. PubMed ID: 30753497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penicillin Allergy De-labeling Results in Significant Changes in Outpatient Antibiotic Prescribing Patterns.
    Hills T; Arroll N; Duffy E; Capstick J; Jordan A; Fitzharris P
    Front Allergy; 2020; 1():586301. PubMed ID: 35386932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A UK hospital survey to explore healthcare professional views and attitudes to patients incorrectly labelled as penicillin allergic: an antibiotic stewardship patient safety project.
    Wilcock M; Powell N; Sandoe J
    Eur J Hosp Pharm; 2019 Nov; 26(6):329-333. PubMed ID: 31798856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-Lactam Allergy De-labeling in a Pediatric Hospital.
    Meehl S; Salathe C; Cooley C; Jordan-Villegas A; Laham FR; Madala A; Cowart M
    J Pediatr Pharmacol Ther; 2024 Apr; 29(2):169-174. PubMed ID: 38596425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a pharmacist-led penicillin allergy de-labelling ward round: a novel antimicrobial stewardship intervention.
    Devchand M; Kirkpatrick CMJ; Stevenson W; Garrett K; Perera D; Khumra S; Urbancic K; Grayson ML; Trubiano JA
    J Antimicrob Chemother; 2019 Jun; 74(6):1725-1730. PubMed ID: 30869124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "How do I keep this live in my mind?" Allied Health Professionals' perspectives of barriers and enablers to implementing good clinical practice principles in research: a qualitative exploration.
    Wenke R; Roberts S; Angus R; Owusu MA; Weir K
    BMC Health Serv Res; 2023 Mar; 23(1):309. PubMed ID: 36998032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to paediatric penicillin allergy de-labelling in UK secondary care: a regional survey.
    Maduemem K; Clark H; Sohal I; Dawson T; Makwana N;
    Arch Dis Child; 2023 May; 108(5):363-366. PubMed ID: 36535750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and enablers towards benzodiazepine-receptor agonists deprescribing in nursing homes: A qualitative study of stakeholder groups.
    Evrard P; Damiaens A; Patey AM; Grimshaw JM; Spinewine A
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100258. PubMed ID: 37124470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penicillin de-labelling in vancouver, British Columbia, Canada: comparison of approaches, outcomes and future directions.
    Saravanabavan S; Aulakh A; Douglas J; Elwood C; Erdle S; Grant J; Kang KT; Kwan N; Lacaria K; Lau TTY; Lee C; Leung V; Lin YC; Mah A; Nguyen A; Paquette V; Roberts A; Watt M; Van Schalkwyk J; Zhang BY; Mak R; Wong T
    Allergy Asthma Clin Immunol; 2023 Apr; 19(1):30. PubMed ID: 37072861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of direct two-step penicillin challenges with an inpatient pharmacist-driven allergy evaluation.
    Ham Y; Sukerman ES; Lewis JS; Tucker KJ; Yu DL; Joshi SR
    Allergy Asthma Proc; 2021 Mar; 42(2):153-159. PubMed ID: 33685561
    [No Abstract]   [Full Text] [Related]  

  • 18. Understanding the clinical management of obstructive sleep apnoea in tetraplegia: a qualitative study using the theoretical domains framework.
    Graco M; Berlowitz DJ; Green SE
    BMC Health Serv Res; 2019 Jun; 19(1):405. PubMed ID: 31226999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and Feasibility of Pharmacist-Driven Penicillin Allergy De-Labeling Pilot Program without Skin Testing or Oral Challenges.
    Song YC; Nelson ZJ; Wankum MA; Gens KD
    Pharmacy (Basel); 2021 Jul; 9(3):. PubMed ID: 34287342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.